Technical Analysis for ABEO - Abeona Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 7.26 1.97% 0.14
ABEO closed up 1.97 percent on Friday, January 18, 2019, on 31 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ABEO trend table...

Date Alert Name Type % Chg
Jan 18 Bollinger Band Squeeze Range Contraction 0.00%
Jan 17 20 DMA Support Bullish 1.97%
Jan 17 Bollinger Band Squeeze Range Contraction 1.97%
Jan 16 180 Bearish Setup Bearish Swing Setup 3.42%
Jan 16 Bollinger Band Squeeze Range Contraction 3.42%
Jan 16 BB Squeeze Started Range Contraction 3.42%
Jan 15 Crossed Above 20 DMA Bullish 0.69%
Jan 15 Outside Day Range Expansion 0.69%
Jan 14 Fell Below 20 DMA Bearish 4.16%
Jan 14 Narrow Range Bar Range Contraction 4.16%

Older signals for ABEO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Is ABEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.0
52 Week Low 6.26
Average Volume 661,983
200-Day Moving Average 13.0577
50-Day Moving Average 7.636
20-Day Moving Average 6.9935
10-Day Moving Average 7.208
Average True Range 0.4505
ADX 12.59
+DI 19.986
-DI 18.2115
Chandelier Exit (Long, 3 ATRs ) 6.3285
Chandelier Exit (Short, 3 ATRs ) 7.6115
Upper Bollinger Band 7.5785
Lower Bollinger Band 6.4085
Percent B (%b) 0.73
BandWidth 16.729821
MACD Line -0.1443
MACD Signal Line -0.2185
MACD Histogram 0.0741
Fundamentals Value
Market Cap 292.49 Million
Num Shares 40.3 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -11.90
Price-to-Sales 831.55
Price-to-Book 7.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.70
Resistance 3 (R3) 7.67 7.49 7.62
Resistance 2 (R2) 7.49 7.38 7.51 7.60
Resistance 1 (R1) 7.38 7.31 7.44 7.41 7.57
Pivot Point 7.20 7.20 7.23 7.22 7.20
Support 1 (S1) 7.09 7.09 7.15 7.12 6.95
Support 2 (S2) 6.91 7.02 6.93 6.92
Support 3 (S3) 6.80 6.91 6.90
Support 4 (S4) 6.83